Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Chemical constituents from Valeriana polystachya Smith and evaluation of their effects on the acetylcholinesterase and prolyl oligopeptidase activities.

de Ávila JM, Pereira AO, Zachow LL, Gehm AZ, Santos MZ, Mostardeiro MA, Back D, Morel AF, Dalcol II.

Fitoterapia. 2018 Oct 16;131:80-85. doi: 10.1016/j.fitote.2018.10.013. [Epub ahead of print]

PMID:
30339922
2.

Fractures of the anterior process of the calcaneum; a review and proposed treatment algorithm.

Dhinsa BS, Latif A, Walker R, Abbasian A, Back D, Singh S.

Foot Ankle Surg. 2018 Feb 21. pii: S1268-7731(18)30029-8. doi: 10.1016/j.fas.2018.02.004. [Epub ahead of print] Review.

PMID:
30321973
3.

Aging in HIV-Infected Subjects: A New Scenario and a New View.

Negredo E, Back D, Blanco JR, Blanco J, Erlandson KM, Garolera M, Guaraldi G, Mallon P, Moltó J, Serra JA, Clotet B.

Biomed Res Int. 2017;2017:5897298. doi: 10.1155/2017/5897298. Epub 2017 Dec 21. Review.

4.

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.

Marra F, Höner Zu Siederdissen C, Khoo S, Back D, Schlag M, Ouwerkerk-Mahadevan S, Bicer C, Lonjon-Domanec I, Jessner W, Beumont-Mauviel M, Kalmeijer R, Cornberg M.

Br J Clin Pharmacol. 2018 May;84(5):961-971. doi: 10.1111/bcp.13519. Epub 2018 Feb 21.

5.

Crystal structure of cis-1-phenyl-8-(pyridin-2-ylmeth-yl)dibenzo[1,2-c:2,1-h]-2,14-dioxa-8-aza-1-borabi-cyclo-[4.4.0]deca-3,8-diene.

Ledesma G, Signorella S, Back D, Schulz Lang E.

Acta Crystallogr E Crystallogr Commun. 2017 Nov 21;73(Pt 12):1917-1920. doi: 10.1107/S2056989017016553. eCollection 2017 Dec 1.

6.

Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals.

Jackson A, Else L, Higgs C, Karolia Z, Khoo S, Back D, Devitt E, Pozniak A, Boffito M.

HIV Clin Trials. 2018 Feb;19(1):31-37. doi: 10.1080/15284336.2017.1408928. Epub 2017 Nov 30.

PMID:
29189101
7.

2-Drug regimens in HIV treatment: pharmacological considerations.

Back D.

Germs. 2017 Sep 1;7(3):113-114. doi: 10.18683/germs.2017.1115. eCollection 2017 Sep. No abstract available.

8.

Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.

Watson J, Toner P, Day E, Back D, Brady LM, Fairhurst C, Renwick C, Templeton L, Akhtar S, Lloyd C, Li J, Cocks K, Ambegaokar S, Parrott S, McArdle P, Gilvarry E, Copello A.

Health Technol Assess. 2017 Mar;21(15):1-260. doi: 10.3310/hta21150.

9.

Subchondral haematoma.

Wharton R, Austin S, Back D.

Hamostaseologie. 2017;37(2):104-106. doi: 10.5482/HAMO-15-12-0033. Epub 2017 Dec 28.

PMID:
29582910
10.

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

Moltó J, Rajoli R, Back D, Valle M, Miranda C, Owen A, Clotet B, Siccardi M.

J Antimicrob Chemother. 2017 Mar 1;72(3):805-811. doi: 10.1093/jac/dkw485.

PMID:
27999009
11.

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.

Fox J, Tiraboschi JM, Herrera C, Else L, Egan D, Dickinson L, Jackson A, Olejniczak N, Back D, Khoo S, Shattock R, Boffito M.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):252-257.

PMID:
27727157
12.

Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.

Degasperi E, Caprioli F, El Sherif O, Back D, Colombo M, Aghemo A.

Expert Rev Gastroenterol Hepatol. 2016 Dec;10(12):1373-1383. Epub 2016 Oct 20. Review.

13.

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.

McGowan I, Dezzutti CS, Siegel A, Engstrom J, Nikiforov A, Duffill K, Shetler C, Richardson-Harman N, Abebe K, Back D, Else L, Egan D, Khoo S, Egan JE, Stall R, Williams PE, Rehman KK, Adler A, Brand RM, Chen B, Achilles S, Cranston RD.

Lancet HIV. 2016 Dec;3(12):e569-e578. doi: 10.1016/S2352-3018(16)30113-8. Epub 2016 Sep 16.

PMID:
27658864
14.

Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.

Marzolini C, Rajoli R, Battegay M, Elzi L, Back D, Siccardi M.

Clin Pharmacokinet. 2017 Apr;56(4):409-420. doi: 10.1007/s40262-016-0447-7.

PMID:
27599706
15.

Subchondral haematoma. The missing link in understanding haemophilic arthropathy?

Wharton R, Austin S, Back D.

Hamostaseologie. 2017 May 10;37(2):104-106. doi: 10.5482/HAMO-15-12-0033. Epub 2016 Jun 1. Review.

PMID:
27598535
16.

Erratum to "Non-resurfacing techniques in the management of the patella at total knee arthroplasty: A systematic review and meta-analysis" [The Knee 23 (2016) 191-197].

Findlay I, Wong F, Smith C, Back D, Davies A, Ajuied A.

Knee. 2016 Oct;23(5):920-921. doi: 10.1016/j.knee.2016.06.013. Epub 2016 Jul 7. No abstract available.

PMID:
27396527
17.

Isolated Disruption of the Right Coronary Artery Following a Steam Pop during Cavotricuspid Linear Ablation with a Contact Force Catheter.

Brunelli M, Frommhold M, Back D, Mierzwa M, Lauer B, Geller JC.

Pacing Clin Electrophysiol. 2016 Jul;39(7):771-3. doi: 10.1111/pace.12832. Epub 2016 Mar 15.

PMID:
27378561
18.

The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma.

Penchala SD, Fawcett S, Else L, Egan D, Amara A, Elliot E, Challenger E, Back D, Boffito M, Khoo S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 1;1027:174-80. doi: 10.1016/j.jchromb.2016.05.040. Epub 2016 May 27.

PMID:
27290668
19.

Diagnostic Efficacy of 3-T MRI for Knee Injuries Using Arthroscopy as a Reference Standard: A Meta-Analysis.

Smith C, McGarvey C, Harb Z, Back D, Houghton R, Davies A, Ajuied A.

AJR Am J Roentgenol. 2016 Aug;207(2):369-77. doi: 10.2214/AJR.15.15795. Epub 2016 Jun 1.

PMID:
27248283
20.

Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study.

Olagunju A, Bolaji O, Neary M, Back D, Khoo S, Owen A.

Pharmacogenet Genomics. 2016 Aug;26(8):381-9. doi: 10.1097/FPC.0000000000000227.

PMID:
27195527

Supplemental Content

Loading ...
Support Center